Skip to main content
OpenTrials
Completed

NCT Number: NCT06012474

Effect Of Power Breath Device On Arterial Blood Gases And Diaphragmatic Excursion After Valve Surgery

The aim of this study is to evaluate the effect of power breath device on arterial blood gases, diaphragmatic excursion and the 6 min walk test after cardiac valve surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Valve Diseases Cardiovascular Diseases Heart Diseases

Age range

25 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Outpatient clinic faculty of physical therapy cairo university

Dokki, Egypt

About this study

No more studies have been done on the effect of IMT by power breath on valvular surgery, So, this study will see the effect of power breath device on arterial blood gases, diaphragmatic excursion and six minute walk test after valve surgery to know enhanced recovery protocols in valvular surgery that accelerate the functional recovery, minimize the length of the hospital stay and decrease cost of treatment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female patients with valve surgery (valve replacement or repair with median sternotomy procedure).
  • Age between 25 to 35 years old.
  • BMI is between 18.5 to 24.5 kg/m2.

Exclusion criteria

The participants will be excluded if they meet one of the following criteria:

  • Uncontrolled hypertension (systolic blood pressure>230 mm Hg and diastolic blood pressure>120 mm Hg)
  • Patients with coronary artery disease or heart failure.
  • Need for mechanical ventilation for >24 h or reintubation.
  • Renal and hepatic disorders.
  • Infected or unstable sternum.
  • patient with pneumothorax after surgery.
  • Metabolic disorders.
  • Pregnant woman.
  • Lactating mother.
  • Smokers
  • Stroke patient

Treatment and study plan

Power breath plus

Other

Power breath plus use a variable load calibrated spring. It can be adjusted from the lowest load setting (17cmH2O) when training began and increased as the patient breathing muscles adapt and become stronger (maximum load setting 274cmH2O). Use a comfortable chair, preferably straight-back so that the spine is straight at all times during the exercise. patients will be instructed to exhale calmly, followed by a maximal forced inspiration to total lung capacity using a mouthpiece and a nasal clip as an aid to prevent air leaks and will ask to make 10 breaths for 3 sets once daily for 7 days with 2min rest between sets

Incrementing the training load

Other

The resistance will be increased incrementally, based on the rate of perceived exertion (RPE) scored by the patient on the modified Borg Scale. If the RPE is less than 5, the resistance of the inspiratory trainer will be increased incrementally by 2cmH2O. The resistance will not change if the level of perceived exertion is rated from 6 to 8, and the resistance will be decreased by 1 to 2 cmH2O if the level of perceived exertion is rated 9 or 10.

Diaphragmatic breathing exercises

Other

Training by using incentive spirometer:

  • Loosen any tight clothing, especially around neck.
  • Each patient will be instructed to sit upright with placing incentive spirometer at the same level of his mouth to promote optimal lung expansion while using the spirometer.
  • The patient will be instructed to exhale letting all the breath out.
  • patient will asked to close the lips around the mouthpiece of the spirometer.
  • patient will be instructed to inhale slowly, breathing in until unable to do any more, this would raise the balls to the top of the column.
  • patient will be asked to hold the breath as long as possible (at least five seconds) then exhale slowly.
  • Session will be in the form of 30 times in sets, each set consist of 5-6 repetitions with rest 1 minute between sets.
  • Intensity of exercise will be increased by increasing time of session, time of holding the breath and numbers of repetitions according to patient's status.

Primary outcomes

  1. Assessing the change in diaphragmatic excursion

    Time frame: within 24 hours after 1 week of intervention

    By using Ultrasonography (Aloka prosound 4000, made in Japan) that will be used to assess diaphragmatic excursion. Diaphragmatic excursion is measured 3 times :at baseline before surgical intervention, second day after surgery (before the training program) and after 7 days of training program for all patient in the two groups. Diaphragmatic excursion was measured during deep breathing while the patient in semi-recumbent position on a comfortable bed using ultrasonography.

  2. Assessing the change in Arterial Blood gases

    Time frame: within 24 hours after 1 week of intervention

    Arterial blood gases are measured at baseline before surgical intervention, second day after surgery (before the training program) and after 7 days of training program for all patient in the two groups and can be obtained by direct arterial puncture most usually at the wrist (radial artery), femoral and brachial artery. An arterial blood sample (2 to 3 ml) will be collected.

  3. Assessing the change in capacity to perform daily activities

    Time frame: within 24 hours after 1 week of intervention

    by using the The 6-min walk test (6MWT) is a submaximal functional test indicative of the capacity to perform daily activities, patients will be asked to walk along a 30-m, flat and straight hospital corridor. Encouragement will be offered every minute, so that subjects will walk as far as possible. Symptom-limited interruptions (dyspnea, skeletal muscle pain, angina, dizziness) will allowed, though patients will be invited to resume walking as soon as possible. Most tests will be supervised by a physical therapist. Distance will be recorded in meters. Subjective dyspnea will quantified according to Borg Scale, ranging from 0 (no dyspnea) to 10 (severe dyspnea).

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Aug 25, 2023
Registry last updated
Aug 25, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.